Cipla launches Antiflu to treat Swine Flu Virus

New Delhi: Breaking News! Leading Pharmaceutical company, Cipla has launched Antiflu, which will treat A H1N1 virus or Swine Flu. According to Cipla, Antiflu is the only flu medicine from India to be approved by the World Health Organisation (WHO). Antiflu would be available both as capsules and liquid.

Cipla has kept the price of Antiflu at Rs 475 for 10 capsules. The 75 ml syrup of Antiflu will cost the same. The company has the capacity of producing up to 2 million doses a month to meet the requirement.